FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to surgery, and concerns a method for prediction of effectiveness of prevention by albendazole of postoperative recurrent of cistic echinococcosis. Core of the method is that from lymphocytes of peripheral venous blood DNA is recovered, genotyping of polymorphism of *1F(163A/C) gene of cytochrome P450 CYP1A2 by analysis of polymorphism of lengths of restriction fragments of DNA synthesis polymerase chain reaction products is performed. If observing the genotype CYP1A2F1*C/C, high efficiency of preventing by albendazole of postoperative recurrent of cistic echinococcosis is predicted.
EFFECT: using the invention enables predicting the effectiveness of prevention by albendazole of recurrent cistic echinococcosis with high accuracy.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIATION OF NATURE OF ORIGIN OF RECURRENT CYSTS DURING CYST ECHINOCOCCOSIS | 2015 |
|
RU2591807C1 |
METHOD OF PREDICTION OF CYSTIC ECHINOCOCCOSIS COURSE IN CHILDREN | 2007 |
|
RU2324940C1 |
METHOD OF PERSONALIZED SELECTION OF ANTIPARASITIC THERAPY IN PATIENTS WITH LIVER ECHINOCOCCOSIS | 2023 |
|
RU2810944C1 |
METHOD OF DETECTING PREDISPOSITION AND RESISTANCE TO DEVELOPMENT OF CYST ECHINOCOCCOSIS IN CHILDREN | 2008 |
|
RU2387383C1 |
METHOD OF PREDICTING COMBINED AFFECTION OF ORGANS BY CYSTIC ECHINOCOCCOSIS IN CHILDREN | 2006 |
|
RU2307349C1 |
METHOD FOR PREDICTION OF SUPPURATION OF UNICAMERAL ECHINOCOCCUS CYST IN NONINVASIVE CHILDREN | 2007 |
|
RU2348039C1 |
METHOD FOR PREDICTION OF STERILITY IN WOMEN WORKING IN PETROCHEMICAL PRODUCTION | 2008 |
|
RU2386133C1 |
METHOD OF CYSTIC ECHINOCOCCOSIS CAUSATIVE AGENT IDENTIFICATION IN BIOLOGICAL SAMPLE | 2006 |
|
RU2332465C1 |
METHOD FOR PREDICTING ECHINOCOCCOSIS RECURRENCE | 2006 |
|
RU2313275C1 |
METHOD FOR PREDICTION OF CHRONIC MYELOID LEUKAEMIA DEVELOPMENT RISK | 2019 |
|
RU2726439C1 |
Authors
Dates
2016-11-10—Published
2015-10-05—Filed